0001104659-20-080021.txt : 20200701
0001104659-20-080021.hdr.sgml : 20200701
20200701211551
ACCESSION NUMBER: 0001104659-20-080021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200629
FILED AS OF DATE: 20200701
DATE AS OF CHANGE: 20200701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arroyo Santiago
CENTRAL INDEX KEY: 0001706857
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 201006915
MAIL ADDRESS:
STREET 1: C/O MOMENTA PHARMACEUTICALS, INC.
STREET 2: 675 WEST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
a4.xml
4
X0306
4
2020-06-29
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001706857
Arroyo Santiago
C/O MOMENTA PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
SVP, Chief Medical Officer
Common Stock
2020-06-29
4
A
0
15000
0
A
52350
D
Common Stock
2020-06-30
4
S
0
6812
35.1
D
45538
D
Restricted Stock Units
2020-06-29
4
A
0
15000
0
A
Common Stock
15000
45000
D
Shares received pursuant to settlement of Performance Stock Units that were granted on October 17, 2018.
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Each Restricted Stock Unit represents a contingent right to receive one share of MNTA Common Stock.
Subject to the officer's continued employment with the company, 15,000 Restricted Stock Units will vest on June 29, 2021.
/s/ R. Mark Chamberlin as attorney in fact
2020-07-01